(2 intermediate revisions by 2 users not shown) | |||
Line 169: | Line 169: | ||
<img src = "https://static.igem.org/mediawiki/2018/9/9d/T--RHIT--design1.jpg" style="width:80%"> | <img src = "https://static.igem.org/mediawiki/2018/9/9d/T--RHIT--design1.jpg" style="width:80%"> | ||
</center> | </center> | ||
− | <center> Figure 1 </center> | + | <center> Figure 1. Initial breakdown of PET chains to byproducts Ethylene Glycol and Terephthalic acid. </center> |
<br><br> | <br><br> | ||
− | <p>Terephthalic acid is recyclable when purified and is relatively nontoxic. Ethylene glycol, on the other hand, is | + | <p>Terephthalic acid is recyclable when purified and is relatively nontoxic. Ethylene glycol, on the other hand, is toxic when ingested by humans, although it has been proven to be safe for <em>E. coli </em>cells. |
<br><br> | <br><br> | ||
The <em>E. coli</em> will then take the ethylene glycol and utilize it as a carbon source using glycolaldehyde reductase, glycolaldehyde dehydrogenase, glycolate oxidase, and malate synthase. This will result in intermediates of glycolaldehyde, glycolate, and glyoxylate, as well as the product of malate which will be used in the citric acid cycle, as shown in Figure 2 below. </p> | The <em>E. coli</em> will then take the ethylene glycol and utilize it as a carbon source using glycolaldehyde reductase, glycolaldehyde dehydrogenase, glycolate oxidase, and malate synthase. This will result in intermediates of glycolaldehyde, glycolate, and glyoxylate, as well as the product of malate which will be used in the citric acid cycle, as shown in Figure 2 below. </p> | ||
Line 178: | Line 178: | ||
<img src = "https://static.igem.org/mediawiki/2018/3/30/T--RHIT--design2_.jpg"> | <img src = "https://static.igem.org/mediawiki/2018/3/30/T--RHIT--design2_.jpg"> | ||
</center> | </center> | ||
− | <center> Figure 2 </center> | + | <center> Figure 2. Further breakdown of Ethylene Glycol to Malate. </center> |
<br><br> | <br><br> | ||
Line 189: | Line 189: | ||
<img src = "https://static.igem.org/mediawiki/2018/e/ec/T--RHIT--plasmid1.jpg"> | <img src = "https://static.igem.org/mediawiki/2018/e/ec/T--RHIT--plasmid1.jpg"> | ||
</center> | </center> | ||
− | <center> Figure 3 </center> | + | <center> Figure 3. </center> |
</div> | </div> | ||
Line 201: | Line 201: | ||
<div class = "column full_size"> | <div class = "column full_size"> | ||
<br><br> | <br><br> | ||
− | <p> Our team selected the W159H/S238F double mutated enzyme based on the article released in April of 2018. The article analyzed the structure of PETase to design the specific double amino acid mutation. PETase was found to have similar common features to cutinases and lipases, which are also shown to partially degrade PET. The double mutation changes the PETase structure by narrowing the binding cleft to better resemble cutinase. In Figure 5 below, which comes from the article, E shows the proposed structure of the binding site in wild-type PETase, while F shows the proposed structure of the binding site in the W159H/S238F double mutated PETase | + | <p> Our team selected the W159H/S238F double mutated enzyme based on the article released in April of 2018. The article analyzed the structure of PETase to design the specific double amino acid mutation. PETase was found to have similar common features to cutinases and lipases, which are also shown to partially degrade PET. The double mutation changes the PETase structure by narrowing the binding cleft to better resemble cutinase. In Figure 5 below, which comes from the article, E shows the proposed structure of the binding site in wild-type PETase, while F shows the proposed structure of the binding site in the W159H/S238F double mutated PETase [1]. </p> |
<center> | <center> | ||
<img src = "https://static.igem.org/mediawiki/2018/2/2e/T--RHIT--doublemutant.jpg" style="width:70%"> | <img src = "https://static.igem.org/mediawiki/2018/2/2e/T--RHIT--doublemutant.jpg" style="width:70%"> | ||
</center> | </center> | ||
− | <center> Figure 5 [1]</center> | + | <center> Figure 5 Ball and Stick representation of the double mutated PETase chain from the article [1].</center> |
<br><br> | <br><br> | ||
Line 216: | Line 216: | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</html> | </html> |
Latest revision as of 02:47, 13 October 2018